Davis v. Merck & Co., Inc.

357 F. Supp. 2d 974, 2005 U.S. Dist. LEXIS 2799, 2005 WL 433701
CourtDistrict Court, E.D. Texas
DecidedFebruary 24, 2005
Docket9:04-cv-00229
StatusPublished
Cited by1 cases

This text of 357 F. Supp. 2d 974 (Davis v. Merck & Co., Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Davis v. Merck & Co., Inc., 357 F. Supp. 2d 974, 2005 U.S. Dist. LEXIS 2799, 2005 WL 433701 (E.D. Tex. 2005).

Opinion

Order on Plaintiff’s Motion to Remand

CLARK, District Judge.

Defendant Merck & Co., Inc. removed this case more than one year after it was filed. Merck asserts that equitable tolling of the one year limitation to removal should be allowed because Plaintiff fraudulently joined the non-diverse Defendant, Dr. Haeckler, only to allow him to be dismissed after a year had passed. There is no evidence of an explicit agreement for dismissal as was seen in Tedford v. Warner-Lambert Co., 327 F.3d 423 (5th Cir.2003). Nevertheless, the evidence establishes that Plaintiff never intended to pursue her claims against Dr. Haeckler, and voluntarily abandoned those claims. Therefore, an equitable tolling exception, as outlined in Tedford, should apply, and Plaintiffs Motion to Remand is denied.

I. BACKGROUND

Plaintiff Pearlie Davis filed her original state court petition in Houston County, Texas on May 29, 2003 against diverse Defendant, Merck & Co., Inc., and non-diverse Defendant, Dr. Christopher Heaekler. 1 Plaintiff alleged that the De *976 fendants were responsible for the injuries she suffered as a consequence of her consumption of the prescription drug, Vioxx. Plaintiff alleged six causes of action against the Defendants including negligence, strict liability, misrepresentation, breach of warranty, conspiracy, and fraud.

Under Texas law, Plaintiffs claims against Dr. Haeckler were governed by the Texas Medical Liability and Insurance Improvement Act, Tex.Rev.Civ. Stat. art. 4590i (“MLIIA”). 2 Plaintiff was required to file an expert medical report within 180 days of filing suit to support her claims that Dr. Haeckler was liable for her injuries. See Tex.Rev.Civ. Stat. art. 4590i § 13.01(d).

On October 17, 2003, Defendant Merck timely removed the action claiming that non-diverse Defendant Dr. Haeckler was improperly joined. 3 On March 4, 2004, the Honorable Leonard Davis, of this Court, granted Plaintiffs motion to remand, indicating that at the time of removal, Merck had not established that Plaintiff Davis did not have a justiciable claim against Dr. Haeckler on the theories alleged. 4 See J. Davis’ Memorandum Opinion and Order, dated 2/15/04, Cause No. 9:03-CV-269. The case was remanded back to the state district court in Houston County on March 15, 2004 and the district clerk of the state court verified receipt of the case on May 10, 2004.

When the case was remanded back to state court, Plaintiff Davis made no attempt to secure the expert report she would need to substantiate her claims against Dr. Haeckler. On August 6, 2004, Dr. Haeckler filed his motion to dismiss the claims against him based on Plaintiffs failure to file an expert report in compliance with Tex.Rev.Civ. Stat. art. 4590i § 13.01(e)(3). 5 Plaintiff Davis responded on October 28, 2004, only two days before the state court hearing on the matter. Plaintiff Davis’ response was based primarily on Plaintiffs counsel’s vague assertion that the requirement for the expert report had been mis-calendared. On November 1, 2004, the State Court Judge denied Plaintiff Davis’ request for a thirty-day extension to comply with the requirement of filing an expert report under Tex. Rev.Civ. Stat. art. 4590i § 13.01(g) and *977 dismissed Dr. Haeckler, the only non-diverse defendant in the case.

On November 12, 2004, Merck removed the case to this court for the second time. Merck argues that there is now evidence that Dr. Haeckler had been improperly joined. Merck asserts that since Plaintiff Davis had, in effect, deliberately abandoned her claims against Dr. Haeckler by not making any attempt to file the required expert report, an equitable tolling exception to the one year removal requirement of 28 U.S.C. § 1446(b) should apply pursuant to the spirit of Tedford v. Warner-Lambert Co., 327 F.3d 423 (5th Cir.2003). Plaintiff Davis then filed her second motion to remand on December 10, 2004.

II. LAW & DISCUSSION

A. Time Limitations on Removal

A defendant must file notice of removal within thirty days after receipt of initial pleadings, or if the case stated by the initial pleadings is not removable, within thirty days of receipt of the pleading or document from which it may first be ascertained that the case has become removable. 28 U.S.C. § 1446(b). The statute also provides that a case may not be removed on the basis of diversity more than one year after commencement of the action. 28 U.S.C. § 1446(b).

Merck initially removed the case within thirty days of receiving a copy of the initial pleadings, and within one year of the commencement of the action. The second removal was within thirty days of the dismissal of Dr. Haeckler. However, since this second removal occurred more than one year after the case was filed, is it untimely?

The purpose of the one year limitation of 28 U.S.C. § 1446(b) is to reduce the opportunity for removal after substantial progress has been made in state court. New York Life Ins. Co. v. Deshotel, 142 F.3d 873, 886 (5th Cir.1998). The docket sheet indicates that this case was initially timely removed and remained on the federal docket for a period of approximately- five months. It took approximately two months for that state court to administratively re-docket the case after remand. The state court then heard Dr. Haeckler’s motion to dismiss and Plaintiff Davis’ request for an extension of time and ruled on both matters. No other matters or hearings are reflected on the state court docket.

The court finds there has been little waste of time and resources in the state court. While Congress has not granted federal courts the full diversity jurisdiction authorized by U.S. Const, art. Ill, § 2, cl. 1, the right Congress has granted a diverse defendant to remove a case to a federal court is important, and should not lightly be disregarded. Given the exceptional circumstances surrounding the timing of Merck’s removal notices, it can hardly be said that Merck intended to waive its right to remove this case. Therefore, it is appropriate to consider whether the interests of. justice would be served by equitably tolling the one year limitation period.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Rhodes Ex Rel. Rhodes v. Mariner Health Care, Inc.
516 F. Supp. 2d 611 (S.D. Mississippi, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
357 F. Supp. 2d 974, 2005 U.S. Dist. LEXIS 2799, 2005 WL 433701, Counsel Stack Legal Research, https://law.counselstack.com/opinion/davis-v-merck-co-inc-txed-2005.